Latest & greatest articles for calcium

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on calcium or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on calcium and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for calcium

141. Randomized Controlled Trial of Febuxostat Versus Allopurinol or Placebo in Individuals with Higher Urinary Uric Acid Excretion and Calcium Stones (PubMed)

Randomized Controlled Trial of Febuxostat Versus Allopurinol or Placebo in Individuals with Higher Urinary Uric Acid Excretion and Calcium Stones Higher urinary uric acid excretion is a suspected risk factor for calcium oxalate stone formation. Febuxostat, a xanthine oxidoreductase inhibitor, is effective in lowering serum urate concentration and urinary uric acid excretion in healthy volunteers and people with gout. This work studied whether febuxostat, compared with allopurinol and placebo (...) , would reduce 24-hour urinary uric acid excretion and prevent stone growth or new stone formation.In this 6-month, double-blind, multicenter, randomized controlled trial, hyperuricosuric participants with a recent history of calcium stones and one or more radio-opaque calcium stone ≥ 3 mm (as seen by multidetector computed tomography) received daily febuxostat at 80 mg, allopurinol at 300 mg, or placebo. The primary end point was percent change from baseline to month 6 in 24-hour urinary uric acid

Full Text available with Trip Pro

2013 EvidenceUpdates Controlled trial quality: predicted high

142. Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis

Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta (...) -analysis Jamal SA, Vandermeer B, Raggi P, Mendelssohn DC, Chatterley T, Dorgan M, Lok CE, Fitchett D, Tsuyuki RT CRD summary This review concluded that non-calcium-based phosphate binders were associated with a decreased risk of all-cause mortality compared with calcium-based phosphate binders in patients with chronic kidney disease. This was a generally well-conducted review but the conclusions seem overly strong. Authors' objectives To update a prior meta-analysis that compared the effect of calcium

2013 DARE.

143. Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. (PubMed)

Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Phosphate binders (calcium-based and calcium-free) are recommended to lower serum phosphate and prevent hyperphosphataemia in patients with chronic kidney disease, but their effects on mortality and cardiovascular outcomes are unknown. We aimed to update our meta-analysis on the effect of calcium-based versus non-calcium-based (...) phosphate binders on mortality in patients with chronic kidney disease.We did a systematic review of articles published in any language after Aug 1, 2008, up until Oct 22, 2012, by searching Medline, Embase, International Pharmaceutical Abstracts, Cochrane Central Register of Controlled Trials, and Cumulative Index to Nursing and Allied Health Literature. We included all randomised and non-randomised trials that compared outcomes between patients with chronic kidney disease taking calcium-based

2013 Lancet

144. Alpha blockers v calcium blockers to increase spontaneous passage of renal calculi

Alpha blockers v calcium blockers to increase spontaneous passage of renal calculi BestBets: Alpha blockers v calcium blockers to increase spontaneous passage of renal calculi Alpha blockers v calcium blockers to increase spontaneous passage of renal calculi Report By: Alexander Stewart - 4th Year Medical Student Search checked by Craig Ferguson - Consultant in Emergency Medicine Institution: Manchester University Date Submitted: 11th July 2012 Date Completed: 17th April 2013 Last Modified (...) : 17th April 2013 Status: Green (complete) Three Part Question In [adult patients with urinary calculi] is [treatment with alpha receptor blockers superior to treatment with calcium channel antagonists] at [increasing the speed and success of spontaneous stone passage]? Clinical Scenario A 51 year old presents to A&E with loin pain and macroscopic haematuria and a diagnosis of renal calculi is made. The patient’s pain is adequately controlled and the decision is discharge with Medical Expulsive

2013 BestBETS

145. An angiotensin II receptor blocker-calcium channel blocker combination prevents cardiovascular events in elderly high-risk hypertensive patients with chronic kidney disease better than high-dose angiotensin II receptor blockade alone (PubMed)

An angiotensin II receptor blocker-calcium channel blocker combination prevents cardiovascular events in elderly high-risk hypertensive patients with chronic kidney disease better than high-dose angiotensin II receptor blockade alone The OSCAR study was a multicenter, prospective randomized open-label blinded end-point study of 1164 Japanese elderly hypertensive patients comparing the efficacy of angiotensin II receptor blocker (ARB) uptitration to an ARB plus calcium channel blocker (CCB

Full Text available with Trip Pro

2013 EvidenceUpdates Controlled trial quality: uncertain

146. Coronary artery calcium score prediction of all cause mortality and cardiovascular events in people with type 2 diabetes: systematic review and meta-analysis. (PubMed)

Coronary artery calcium score prediction of all cause mortality and cardiovascular events in people with type 2 diabetes: systematic review and meta-analysis. To investigate the association of coronary artery calcium score with all cause mortality and cardiovascular events in people with type 2 diabetes.Systematic review and meta-analysis of observational studies.Studies were identified from Embase, PubMed, and abstracts from the 2011 and 2012 annual meetings of the American Diabetes (...) Association, European Association for the Study of Diabetes, American College of Cardiology, and American Heart Association (2011).Prospective studies that evaluated baseline coronary artery calcium score in people with type 2 diabetes and subsequent all cause mortality or cardiovascular events (fatal and non-fatal).Two independent reviewers extracted the data. The predictive value of the coronary artery calcium score was assessed by random effects model.Eight studies were included (n=6521; 802 events

Full Text available with Trip Pro

2013 BMJ

147. Do calcium supplements increase the risk of myocardial infarction?

Do calcium supplements increase the risk of myocardial infarction? Do calcium supplements increase the risk of myocardial infarction? – Morsels of Evidence \t\t\t\r\n\t\t\t \t\t\t\r\n\t\t\t Like this: Like Loading... ","author":{"@type":"Person","name":"Michael Tam"},"image":["https:\/\/evidencebasedmedicine.com.au\/wp-content\/uploads\/2014\/02\/MO_Ca_supplements-219x300.png"]} Toggle search form Toggle navigation Evidence-based medicine for general practitioners Mar 15 2013 Do calcium (...) supplements increase the risk of myocardial infarction? By in , , Journal reference: Bolland M, Avenell A, Baron JA, Grey A, MacLennan GS, Gamble GD, Reid IR. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 2010; 341: c3691 Link: Published: 30 July 2010 Evidence cookie says… Calcium supplements may increase the risk of myocardial infarction, but, there is substantial uncertainty in the estimate . For every 69 patients treated with calcium

Full Text available with Trip Pro

2013 Morsels of Evidence

148. Mineral Trioxide Aggregate Superior to Calcium Hydroxide in Pulpotomized Primary Molars

Mineral Trioxide Aggregate Superior to Calcium Hydroxide in Pulpotomized Primary Molars UTCAT2415, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title Mineral Trioxide Aggregate Superior to Calcium Hydroxide in Pulpotomized Primary Molars Clinical Question In pulpotomized primary dentition, does Mineral Trioxide Aggregate produce superior results as compared to Calcium Hydroxide? Clinical Bottom Line Mineral Trioxide (...) Aggregate yielded superior results when used in primary molars in both radiographic and clinical findings. Best Evidence (you may view more info by clicking on the PubMed ID link) PubMed ID Author / Year Patient Group Study type (level of evidence) #1) Liu/2011 17 children Randomized Controlled Trial Key results In the treatment primary molars with MTA, the success rate was 94.1% with crown discoloration being the common complaint. In primary molars treated with Calcium Hydroxide, internal root

2013 UTHSCSA Dental School CAT Library

149. Backfilling of iliac crest defects with hydroxyapatite-calcium triphosphate biphasic compound: a prospective, randomized computed tomography and patient-based analysis (PubMed)

Backfilling of iliac crest defects with hydroxyapatite-calcium triphosphate biphasic compound: a prospective, randomized computed tomography and patient-based analysis Hydroxyapatite-calcium triphosphate (HCT) biphasic compounds are known to be efficacious in filling bone voids. No large study to date has assessed their radiographic efficacy in iliac crest voids with computed tomography (CT) analysis at a 2-year follow-up.To assess whether backfilling iliac crest defects with HCT biphasic

2013 EvidenceUpdates Controlled trial quality: uncertain

150. Vitamin D and Calcium Supplementation to Prevent Fractures in Adults: U.S. Preventive Services Task Force Recommendation Statement. (PubMed)

Vitamin D and Calcium Supplementation to Prevent Fractures in Adults: U.S. Preventive Services Task Force Recommendation Statement. New U.S. Preventive Services Task Force (USPSTF) recommendation statement on vitamin D and calcium supplementation to prevent fractures in adults.The USPSTF commissioned 2 systematic evidence reviews and a meta-analysis on vitamin D supplementation with or without calcium to assess the effects of supplementation on bone health outcomes in community-dwelling adults (...) , the association of vitamin D and calcium levels with bone health outcomes, and the adverse effects of supplementation.These recommendations apply to noninstitutionalized or community-dwelling asymptomatic adults without a history of fractures. This recommendation does not apply to the treatment of persons with osteoporosis or vitamin D deficiency.The USPSTF concludes that the current evidence is insufficient to assess the balance of the benefits and harms of combined vitamin D and calcium supplementation

Full Text available with Trip Pro

2013 Annals of Internal Medicine

151. Long term calcium intake and rates of all cause and cardiovascular mortality: community based prospective longitudinal cohort study. (PubMed)

Long term calcium intake and rates of all cause and cardiovascular mortality: community based prospective longitudinal cohort study. To investigate the association between long term intake of dietary and supplemental calcium and death from all causes and cardiovascular disease.Prospective longitudinal cohort study.Swedish mammography cohort, a population based cohort established in 1987-90.61 433 women (born between 1914 and 1948) followed-up for a median of 19 years.Primary outcome measures (...) , identified from registry data, were time to death from all causes (n=11 944) and cause specific cardiovascular disease (n=3862), ischaemic heart disease (n=1932), and stroke (n=1100). Diet was assessed by food frequency questionnaires at baseline and in 1997 for 38 984 women, and intakes of calcium were estimated. Total calcium intake was the sum of dietary and supplemental calcium.The risk patterns with dietary calcium intake were non-linear, with higher rates concentrated around the highest intakes

Full Text available with Trip Pro

2013 BMJ

152. Calcium and vitamin D supplementation and cognitive impairment in the women`s health initiative (PubMed)

Calcium and vitamin D supplementation and cognitive impairment in the women`s health initiative To examine the effects of vitamin D and calcium on cognitive outcomes in elderly women.Post hoc analysis of a randomized double-blind placebo-controlled trial.Forty Women's Health Initiative (WHI) clinical centers across the United States.Four thousand one hundred forty-three women aged 65 and older without probable dementia at baseline who participated in the WHI Calcium and Vitamin D Trial (...) and the WHI Memory Study.Two thousand thirty-four women were randomized to receive 1,000 mg of calcium carbonate combined with 400 IU of vitamin D(3) (treatment) and 2,109 to placebo.Primary: classifications of probable dementia or mild cognitive impairment (MCI) based on a four-phase protocol that included central adjudication. Secondary: global cognitive function and individual cognitive subtests.Mean age of participants was 71. During a mean follow-up of 7.8 years, 39 participants in the treatment

Full Text available with Trip Pro

2013 EvidenceUpdates Controlled trial quality: predicted high

153. Improvement of Symptoms in Patients With Polycystic Ovarian Syndrome by Vitamin D and Calcium Supplementation

Improvement of Symptoms in Patients With Polycystic Ovarian Syndrome by Vitamin D and Calcium Supplementation "Improvement of Symptoms in Patients With Polycystic Ovarian Syndrome b" by Alyssa M. Galusha < > > > > > Title Author Date of Graduation Summer 8-10-2013 Degree Type Capstone Project Degree Name Master of Science in Physician Assistant Studies Rights . Abstract Background: Polycystic ovarian syndrome (PCOS) is a common female endocrine disorder with unknown etiology. Many treatments (...) are available to treat the symptoms associated with this condition including obesity, insulin resistance, abnormal glucose metabolism, infertility, menstrual irregularity, hirsutism, and acne vulgaris. More recently, it has been found that women with PCOS, particularly if obese, are more likely to be vitamin D deficient. It is hypothesized that vitamin D and calcium metabolism can also affect symptoms associated with PCOS as it influences many physiologic processes within the body. Does vitamin D

2013 Pacific University EBM Capstone Project

154. Vitamin D and Calcium to Prevent Fractures: Preventive Medication

Vitamin D and Calcium to Prevent Fractures: Preventive Medication Final Update Summary: Vitamin D and Calcium to Prevent Fractures: Preventive Medication - US Preventive Services Task Force Search USPSTF Website Text size: Assembly version: 1.0.0.308 Last Build: 11/16/2018 6:27:19 PM You are here: Final Update Summary : Final Update Summary Archived: Vitamin D and Calcium to Prevent Fractures: Preventive Medication Original Release Date: February 2013 This version of this topic is currently (...) archived and inactive. It should be used for historical purposes only. Archived: Recommendation Summary Summary of Recommendations and Evidence Population Recommendation Grade Premenopausal Women The USPSTF concludes that the current evidence is insufficient to assess the balance of the benefits and harms of combined vitamin D and calcium supplementation for the primary prevention of fractures in premenopausal women. Go to the for suggestions for practice regarding the I statements. Men The USPSTF

2013 U.S. Preventive Services Task Force

155. MICrocephaly, disproportionate pontine and cerebellar hypoplasia syndrome: A clinico-radiologic phenotype linked to calcium/calmodulin-dependent serine protein kinase gene mutation (PubMed)

MICrocephaly, disproportionate pontine and cerebellar hypoplasia syndrome: A clinico-radiologic phenotype linked to calcium/calmodulin-dependent serine protein kinase gene mutation MICrocephaly, disproportionate pontine and cerebellar hypoplasia (MICPCH) syndrome, a rare X-linked disorder, generally seen in girls, is characterized by neurodevelopmental delay, microcephaly, and disproportionate pontine and cerebellar hypoplasia. It is caused by inactivating calcium/calmodulin-dependent serine

Full Text available with Trip Pro

2013 Indian journal of human genetics

156. Population Screening Act: calcium score and the risk of cardiovascular disease

Population Screening Act: calcium score and the risk of cardiovascular disease Population Screening Act: calcium score and the risk of cardiovascular disease Population Screening Act: calcium score and the risk of cardiovascular disease Health Council of the Netherlands Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Health Council of the Netherlands. Population (...) Screening Act: calcium score and the risk of cardiovascular disease. The Hague: Health Council of the Netherlands Gezondheidsraad (GR). 2013/09. 2013 Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Calciums; Cardiovascular Diseases; Predictive Value of Tests Language Published English Country of organisation Netherlands English summary An English language summary is available. Address for correspondence Postbus 16052, 2500 BB Den Haag, The Netherlands. Tel: +31 70 340 7520

2013 Health Technology Assessment (HTA) Database.

157. Calcium supplementation in pregnant women

Calcium supplementation in pregnant women WHO | Archived: Calcium supplementation in pregnant women Archived This publication and its contents has been superseded by a more recent version. It is here for reference purposes. Please follow WHO Regional websites Access Nutrition Menu Archived: Calcium supplementation in pregnant women Guideline Authors : WHO Publication details Number of pages : 30 Publication date : 2013 Languages : English ISBN : 978 92 4 150537 6 Downloads pdf, 1.81Mb Overview (...) This guideline provides global, evidence-informed recommendations on the use of calcium supplements as a public health intervention for the purpose of improving pregnancy outcomes. Poor maternal and newborn health and nutrition remain significant contributors to the burden of disease and mortality. Calcium supplementation has the potential to reduce adverse gestational outcomes, in particular, by decreasing the risk of developing hypertensive disorders during pregnancy, which are associated

2013 World Health Organisation Guidelines

158. Higher dietary intakes of potassium, calcium and magnesium are associated with a reduced risk of developing vascular dementia

Higher dietary intakes of potassium, calcium and magnesium are associated with a reduced risk of developing vascular dementia Higher dietary intakes of potassium, calcium and magnesium are associated with a reduced risk of developing vascular dementia | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log (...) in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Higher dietary intakes of potassium, calcium and magnesium are associated with a reduced risk of developing vascular dementia Article Text

2013 Evidence-Based Mental Health

159. Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis.

Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Phosphate binders (calcium-based and calcium-free) are recommended to lower serum phosphate and prevent hyperphosphataemia in patients with chronic kidney disease, but their effects on mortality and cardiovascular outcomes are unknown. We aimed to update our meta-analysis on the effect of calcium-based versus non-calcium-based (...) phosphate binders on mortality in patients with chronic kidney disease.We did a systematic review of articles published in any language after Aug 1, 2008, up until Oct 22, 2012, by searching Medline, Embase, International Pharmaceutical Abstracts, Cochrane Central Register of Controlled Trials, and Cumulative Index to Nursing and Allied Health Literature. We included all randomised and non-randomised trials that compared outcomes between patients with chronic kidney disease taking calcium-based

2013 Lancet

160. Cohort study: Opposite impacts of dietary versus supplemental calcium on cardiovascular health

Cohort study: Opposite impacts of dietary versus supplemental calcium on cardiovascular health Opposite impacts of dietary versus supplemental calcium on cardiovascular health | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Opposite impacts of dietary versus supplemental calcium on cardiovascular health Article Text Prognosis Cohort study Opposite impacts of dietary versus supplemental calcium on cardiovascular health Idris Guessous 1 , 2

2013 Evidence-Based Medicine (Requires free registration)